SCHEMBL22840323

SCHEMBL22840323

CC1CCN(C(=O)c2cc(F)ccn2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.50
RAB9A P51151 4/20 0.50
HPGD P15428 5/20 0.48
SMN1; SMN2 Q16637 5/20 0.48
ACHE P22303 1/20 0.48
THRB P10828 1/20 0.47
ALDH1A1 P00352 3/20 0.47
TP53 P04637 2/20 0.47
TRPC3 Q13507 3/20 0.47
TRPC6 Q9Y210 3/20 0.47
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
LMNA P02545 1/20 0.45
TSHR P16473 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
HRH3 Q9Y5N1 1/20 0.45
APOBEC3A P31941 1/20 0.45
APOBEC3G Q9HC16 1/20 0.45
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15070505 0.84 ALDH1A1 (0.51) NPC1RAB9AHPGDSMN1; SMN2ACHE
SCHEMBL13744784 0.78 L3MBTL1 (0.73) NPC1RAB9AHPGDSMN1; SMN2ACHE
SCHEMBL30484494 0.77 ALDH1A1 (0.51) NPC1RAB9AHPGDSMN1; SMN2ACHE
SCHEMBL17546317 0.75 CYP3A4 (0.53) HPGDACHEALDH1A1APOBEC3AAPOBEC3G
SCHEMBL13450341 0.74 SMN1; SMN2 (0.61) HPGDSMN1; SMN2ACHEKDM4EHSD11B1
SCHEMBL17546311 0.74 ACHE (0.50) NPC1RAB9AHPGDSMN1; SMN2ACHE
SCHEMBL13504099 0.74 SMN1; SMN2 (0.68) NPC1RAB9AHPGDSMN1; SMN2ACHE
SCHEMBL12753374 0.73 HSD11B1 (0.60) NPC1RAB9AHPGDSMN1; SMN2THRB
SCHEMBL13450575 0.72 HSD11B1 (0.60) NPC1RAB9AHPGDSMN1; SMN2ACHE
SCHEMBL22972377 0.72 SMYD3 (0.49) NPC1RAB9AHPGDL3MBTL1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3535267-B1 [1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AS PDE2 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2020-12-30 EP disclosed